Literature DB >> 24161209

Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome.

Won Sup Oh1, Sang Taek Heo2, Sun Hyung Kim3, Won Jun Choi4, Myung Guk Han5, Ji Young Kim6.   

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease caused by a novel bunyavirus. Although the increasing numbers of cases and deaths is of great concern, an effective treatment strategy for SFTS has not been established. We present the cases of two patients with rapidly progressing SFTS who were successfully treated with plasma exchange and ribavirin.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bunyavirus; Plasma exchange; Ribavirin; Severe fever with thrombocytopenia syndrome

Mesh:

Substances:

Year:  2013        PMID: 24161209     DOI: 10.1016/j.ijid.2013.08.011

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  26 in total

Review 1.  The Emergence of Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Jesus A Silvas; Patricia V Aguilar
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

2.  Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis.

Authors:  Younho Choi; Su-Jin Park; Yinyan Sun; Ji-Seung Yoo; Raghavendra Sumanth Pudupakam; Suan-Sin Foo; Woo-Jin Shin; Sally B Chen; Philip N Tsichlis; Won-Ja Lee; Jong-Soo Lee; Wenhui Li; Benjamin Brennan; Young-Ki Choi; Jae U Jung
Journal:  Nat Microbiol       Date:  2019-01-07       Impact factor: 17.745

3.  Mild clinical course of severe Fever with thrombocytopenia syndrome virus infection in an elderly Japanese patient.

Authors:  Yuko Ohagi; Shinobu Tamura; Chiaki Nakamoto; Hiromichi Nakamoto; Masayuki Saijo; Masayuki Shimojima; Yoshio Nakano; Tokuzo Fujimoto
Journal:  Case Rep Infect Dis       Date:  2014-12-04

4.  Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Hideki Tani; Aiko Fukuma; Shuetsu Fukushi; Satoshi Taniguchi; Tomoki Yoshikawa; Naoko Iwata-Yoshikawa; Yuko Sato; Tadaki Suzuki; Noriyo Nagata; Hideki Hasegawa; Yasuhiro Kawai; Akihiko Uda; Shigeru Morikawa; Masayuki Shimojima; Haruo Watanabe; Masayuki Saijo
Journal:  mSphere       Date:  2016-01-06       Impact factor: 4.389

5.  Bone Marrow Suppression and Hemophagocytic Histiocytes Are Common Findings in Korean Severe Fever with Thrombocytopenia Syndrome Patients.

Authors:  Sang Yong Shin; Oh Hyun Cho; In Gyu Bae
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

6.  Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome During an Outbreak in South Korea, 2013-2015.

Authors:  Sun-Whan Park; Jungsang Ryou; Woo-Young Choi; Myung-Guk Han; Won-Ja Lee
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

7.  Family Cluster Analysis of Severe Fever with Thrombocytopenia Syndrome Virus Infection in Korea.

Authors:  Jeong Rae Yoo; Sang Taek Heo; Dahee Park; Hyemin Kim; Aiko Fukuma; Shuetsu Fukushi; Masayuki Shimojima; Keun Hwa Lee
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

8.  Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection.

Authors:  Masayuki Shimojima; Shuetsu Fukushi; Hideki Tani; Satoshi Taniguchi; Aiko Fukuma; Masayuki Saijo
Journal:  Virol J       Date:  2015-11-02       Impact factor: 4.099

9.  Severe fever with thrombocytopenia syndrome presenting as acute hepatic failure.

Authors:  Jung Gil Park
Journal:  Clin Exp Emerg Med       Date:  2015-06-30

10.  Use of Plasma Therapy for Severe Fever with Thrombocytopenia Syndrome Encephalopathy.

Authors:  Se Yoon Park; WooYoung Choi; Yong Pil Chong; Sun-Whan Park; Eun Byeol Wang; Won-Ja Lee; Youngmee Jee; Seog-Woon Kwon; Sung-Han Kim
Journal:  Emerg Infect Dis       Date:  2016-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.